Rivalry Capital Launches as Next-Generation Private Equity Firm Focusing on Healthcare Transformation

DENVER–(BUSINESS WIRE)–Rivalry Capital today announced its official launch, introducing a next-generation private equity firm that combines applied mathematics and artificial intelligence with operational depth and clinical expertise. Founded by Jim Chandler CFA, Matt Young MBA, Robert Moghim MD, and Kian Modanlou MD, the firm uses a disciplined, system-based investment approach to identify and accelerate growth in transformative companies reshaping healthcare.

RC %28PNG%29
RC %28PNG%29

“Healthcare will evolve more in the next five years than in the previous two decades,” said Jim Chandler. “Rising systemic demand for greater efficiency, transparency, and accountability has been fueled by a lack of viable alternatives to replace antiquated systems and processes. We see significant growth opportunities emerging as proven alternatives are introduced and adopted at scale.”

Dr. Robert Moghim added, “Our healthcare system has become increasingly fragmented, inflationary, and difficult to navigate. We want to partner with exceptional leaders and companies delivering real improvement to stakeholders across the entire care ecosystem.”

With a track record of driving more than $450 million in cumulative exits throughout their careers, the founding partners provide the foundation for Rivalry Capital’s rigor and credibility.

About Rivalry Capital

Rivalry Capital is a private equity firm focused on investing in emerging and lower middle market companies in the healthcare and technology sectors. The name ‘Rivalry’ was inspired by the founders’ roots at Duke University and the University of North Carolina, two institutions known for one of the most respected rivalries in all of sports. It represents a shared belief that excellence is forged through intense effort, mutual accountability, and an unwavering commitment to rise above challenges. For more information, visit www.rivalrycapital.com and www.linkedin.com/company/rivalry-capital/

Contacts

Jim Chandler, (720) 303-1235

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Stay up-to-date with the latest Newsletters, free of charge.